Certified by Founder Lodge
Volastra Therapeutics
United States - New York, New York
START UP
1 Disclosed Funding Rounds $60,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Volastra Therapeutics is a New York-based drug discovery and therapeutics company pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN), cancer’s most tar
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 08 ,2023 | Series A | $60,000,000 |
Eli Lilly and Company
ARCH Venture Partners
Polaris Partners
Catalio Capital Management
Droia Ventures
Vida Ventures, LLC
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Malama Health | $9,200,000 | (Mar 17, 2026)
Gangkhar | $4,250,000 | (Mar 17, 2026)
Dark Watch | $3,500,000 | (Mar 17, 2026)
Great Sky | $14,000,000 | (Mar 17, 2026)
Scanner | $22,000,000 | (Mar 17, 2026)
